Fundraising Fox
/People
Sign in

Stefan Beyer

Investor

Executive Advisor at Ampersand

Find your path to Stefan

38 people in our graph can introduce you to Stefan.

Sign up to see every warm intro you have to Stefan

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Stefan. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Stefan Beyer joined Ampersand as an Executive Advisor in 2024, drawing on more than 20 years in leadership and business development across the life sciences sector. He previously served as CEO and later President of Vibalogics, a CDMO focused on oncolytic viral vectors and viral vector vaccines that was acquired by Recipharm in 2022, and has experience converting family-owned businesses into investor-backed growth companies. He holds a Ph.D. in biology and biotechnology with a focus on the molecular biology of natural product-producing microorganisms.

Invests in

Biotech

Investments

Board seats

Purna PharmaceuticalsVivebiotech

Per the firm's website.

Colleagues at Ampersand

Aditya V. Goel
Associate at Ampersand
Benoit P. Bouche
Operating Partner at Ampersand
Cole S. Aldrich
Senior Associate at Ampersand
David Q. Anderson
General Partner at Ampersand
Dean D. Schauer
Operating Partner at Ampersand
Elias J. Laimboeck
Senior Associate at Ampersand
Emanuele M. Delfino
Associate at Ampersand
Eric B. Lev
General Partner at Ampersand

Frequently asked questions

Who is Stefan Beyer?
Stefan Beyer joined Ampersand as an Executive Advisor in 2024, drawing on more than 20 years in leadership and business development across the life sciences sector. He previously served as CEO and later President of Vibalogics, a CDMO focused on oncolytic viral vectors and viral vector vaccines that was acquired by Recipharm in 2022, and has experience converting family-owned businesses into investor-backed growth companies. He holds a Ph.D. in biology and biotechnology with a focus on the molecular biology of natural product-producing microorganisms.
Where does Stefan Beyer work?
Stefan Beyer is Executive Advisor at Ampersand.
What does Stefan Beyer invest in?
Stefan Beyer invests in Biotech.
What boards does Stefan Beyer sit on?
Stefan Beyer holds tracked board seats at Purna Pharmaceuticals, Vivebiotech.